Lymphocele Outcomes After Renal Transplantations Performed by an Experienced Surgeon: Is Meticulously Performed Surgery and Experience Adequate to Prevent Lymphocele?

20 February 2024: Original Paper

Nurettin Ay ^1ABCDEF* , Vahhac Alp ^1B , Recai Duymuş ^2BD , Sedat Çetin ^3BD

DOI: 10.12659/AOT.942656

Ann Transplant 2024; 29:e942656

Table 1 Patient, surgical, preoperative, and postoperative variables.

Characteristic	All patients n=315	Nonlymphocele group 233 (74%)	Lymphocele group 82 (26%)	P value
Age	33.45±13.8	33.47±14	33.38±13.3	0.96
Sex, n (%)				0.22
Female	128 (40.6%)	90 (38.6%)	38 (46.3%)
Male	187 (60.4%)	143 (62.4%)	44 (53.7%)

	25 (30.5%)
3–5.9 cm	37 (45.1%)
6–9.9 cm	13 (15.9%)
>10 cm	7 (8.5%)

No intervention	66 (80.5%)
UGPD	12 (14.6%)
UGPD+LF	4 (4.9%)
				0.153
Diabetes mellitus	39 (12.4%)	30 (12.9%)	9 (11%)
Hypertension	96 (30.5%)	66 (28.3%)	30 (36.6%)
Urological pathologies	29 (9.2%)	25 (10.7%)	4 (4.9%)
CGN	42 (13.3%)	26 (11.2%)	16 (19.55)
PKCD	5 (1.6%)	5 (2.1%)	0
NS or NP	62 (19.7%)	46 (19.7%)	16 (19.5%)
Other	20 (6.3%)	17 (7.3%)	3 (3.7%)
Unknown causes	22 (7%)	18 (7.7%)	4 (4.9%)
				0.17
CCF	204 (64.8%)	156 (67%)	48 (58.5%)
Ligation	111 (35.2%)	77 (33%)	34 (41.5%)
UGDP – ultrasound-guided drain placement; ESRD – end-stage renal disease; CGN – chronic glomerulo-nephritis; PKCD – polycystic kidney disease; NS or NP – nephrotic syndrome or nephronophthisis; LF – laparoscopic fenestration; LVC – lymphatic vessel control; CCF – cautery coagulation with forceps.